Early-Stage Breast Cancer

Key Takeaways

Responding quickly and proactively to a breast cancer diagnosis can often make the difference in the success of a treatment.

Although this study had been underway for a year before BBK Worldwide came on board, enrollment was staggeringly low. Our campaign sought to empower women, at the vulnerable point of first diagnosis, to fight back by aggressively seeking information about all treatment options, including clinical study participation. The central concept, female boxing, encouraged open patient-physician discussions by communicating empathy while urging bold action.

Response was so positive that recruitment finished two months ahead of the revised schedule.

Challenges and Insights

• This study had been underway for one year, but had achieved only 25 percent enrollment.
  

• The sponsor needed to enroll 420 patients, within 12 remaining months, into a study of an investigational treatment for breast cancer in post-menopausal women.

• Study participation offered “standard of care ‘plus’” — an opportunity to try a new treatment regimen combining an investigational drug with FDA-approved standard therapies to potentially improve response rates and extend progression-free survival.

• Given that they were providing the patients with their first cancer diagnosis, physicians were somewhat hesitant to broach the topic of clinical study participation; patients, new to the breast cancer landscape, lacked the knowledge or mindsets to inquire proactively.